Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding

Autor: Liza Ho, Frédéric Lajaunias, Carolin Dix, Eduardo Martinez-Soria, Lars Nitschke, Shozo Izui, Shuichi Kikuchi, Thomas Moll, R. Michael E. Parkhouse, Marie-Laure Santiago-Raber
Jazyk: angličtina
Rok vydání: 2017
Předmět:
medicine.drug_class
Sialic Acid Binding Ig-like Lectin 2
Immunology
Genes
MHC Class II

Congenic
ddc:616.07
Signal Transduction/genetics/*immunology
Biology
Monoclonal antibody
Ligands
Immunoglobulin M/genetics/immunology
Mice
Lupus Erythematosus
Systemic/genetics/immunology

immune system diseases
hemic and lymphatic diseases
medicine
Immunology and Allergy
Animals
Lupus Erythematosus
Systemic

RNA Processing
Post-Transcriptional

Alleles
Mice
Knockout

B-Lymphocytes/*immunology
MHC class II
B-Lymphocytes
Mice
Inbred BALB C

Mice
Inbred C3H

Systemic lupus erythematosus
Mice
Inbred NZB

RNA Processing
Post-Transcriptional/genetics/*immunology

CD22
Antigens
CD22/genetics/*immunology

SIGLEC
General Medicine
Ligand (biochemistry)
medicine.disease
Molecular biology
Phenotype
Genes
MHC Class II/genetics/immunology

Gene Expression Regulation
Immunoglobulin M
biology.protein
Gene Expression Regulation/genetics/*immunology
Signal Transduction
Zdroj: International Immunology, Vol. 18, No 1 (2006) pp. 59-68
ISSN: 0953-8178
Popis: CD22 functions primarily as a negative regulator of B-cell receptor signaling. The Cd22a allele has been proposed as a candidate allele for murine systemic lupus erythematosus. In this study, we explored the possible expression of aberrant forms of CD22, which differ in the N-terminal sequences constituting the ligand-binding site due to synthesis of abnormally processed Cd22 mRNA, in several Cd22a mouse strains, including C57BL/6 Cd22 congenic mice. The staining pattern of splenic B cells obtained with CY34 anti-CD22 mAb, which was expected to bind poorly to the aberrant CD22, was more heterogeneous in Cd22(a) mice than in Cd22b mice. Moreover, CD22 detected on B cells of Cd22a mice was expressed more weakly and as a smaller-sized protein, compared with Cd22b mice. Significantly, analysis with a synthetic CD22 ligand demonstrated that Cd22a mice carried a larger proportion of CD22 that was not bound by cis ligands on the B-cell surface than Cd22b mice. Finally, the study of C57BL/6 Cd22 congenic mice revealed that Cd22a B cells displayed a phenotype reminiscent of constitutively activated B cells (reduced surface IgM expression and augmented MHC class II expression), as reported for B cells expressing a mutant CD22 lacking the ligand-binding domain. Our demonstration that Cd22a B cells express aberrant forms of CD22, which can potentially deregulate B-cell signaling because of their decreased ligand-binding capacity, provides further support for Cd22a as a potential candidate allele for murine systemic lupus erythematosus.
Databáze: OpenAIRE